0000899243-20-012163.txt : 20200506 0000899243-20-012163.hdr.sgml : 20200506 20200506190736 ACCESSION NUMBER: 0000899243-20-012163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200504 FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 20854052 MAIL ADDRESS: STREET 1: 333 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia, Inc. CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: MyoKardia Inc DATE OF NAME CHANGE: 20120618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-04 0 0001552451 MyoKardia, Inc. MYOK 0001413822 GIANAKAKOS ANASTASIOS C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 1 1 0 0 President and CEO Common Stock 2020-05-04 4 S 0 1386 56.9317 D 77736 D Common Stock 2020-05-04 4 S 0 400 58.045 D 77336 D Common Stock 2020-05-04 4 S 0 2909 59.0979 D 74427 D Common Stock 2020-05-04 4 S 0 305 60.152 D 74122 D Common Stock 130407 I By Reporting Person's Trust 2 Common Stock 300000 I By Reporting Person's Trust 4 Common Stock 6000 I By Reporting Person's Trust 5 Common Stock 53087 I By Trust 1 Common Stock 53087 I By Trust 2 Common Stock 53087 I By Trust 3 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Represents the weighted average sale price of the shares sold ranging from $56.46 to $57.35 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in footnotes 2, 4, 5 and 6. Includes 95,540 shares previously held by The TKG Trust dated November 2, 2006 which were contributed to the Reporting Person directly on May 1, 2020, and excludes (a) 300,000 shares previously owned directly which were contributed to The Tassos Gianakakos 2020 Annuity Trust on May 1, 2020 and (b) 6,000 shares previously owned directly which were contributed to The TKG 2020 Irrevocable Trust on May 1, 2020. Represents the weighted average price of the shares sold ranging from $57.48 to $58.40 per share. Represents the weighted average price of the shares sold ranging from $58.60 to $59.45 per share. Represents the weighted average price of the shares sold ranging from $59.67 to $60.17 per share. Excludes 95,540 shares previously held by The TKG Trust dated November 2, 2006 which were contributed to the Reporting Person directly on May 1, 2020. Includes 300,000 shares previously owned directly which were contributed to The Tassos Gianakakos 2020 Annuity Trust on May 1, 2020. Includes 6,000 shares previously owned directly which were contributed to The TKG 2020 Irrevocable Trust on May 1, 2020. /s/ Cynthia J. Ladd, as Attorney-in-Fact 2020-05-06